Drug-induced gastrointestinal disorders in surgical patients admitted to the University Hospital, Jena, Germany

International Journal of Clinical Pharmacology and Therapeutics

Volumn 43, Issue 8, 2005, Pages 406-410

  Hippius, Marion ^a   Hegenbart, U ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

ADR; Gastrointestinal diseases; Pharmacovigilance; Surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTACID AGENT; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CORTICOSTEROID DERIVATIVE; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRONE; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANCREATIN; PANTOPRAZOLE; PARACETAMOL; PENTOXIFYLLINE; PHENPROCOUMON; POTASSIUM PERCHLORATE; RANITIDINE; SPIRONOLACTONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COLON PERFORATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; GASTRITIS; GASTROINTESTINAL DISEASE; GERMANY; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; IDIOPATHIC DISEASE; INTESTINE ULCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; MORBIDITY; PATHOGENESIS; PHYSICIAN; POLYPHARMACY; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; STOMACH EROSION; STOMACH ULCER; SURGICAL PATIENT; SYMPTOMATOLOGY; ULCER PERFORATION; UNIVERSITY HOSPITAL; UPPER GASTROINTESTINAL BLEEDING;

EID: 23144447505     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP43406     Document Type: Article

References (22)

1. Alvarez-Requejo A, Carvajal A, Bégaud B, Moride T, Vega L, Martin-Arias LH 1998 Under-reporting of adverse drug reactions - estimate based on a spontanous reporting scheme and a sentinel system. Eur J Clin Pharmacol 54: 483-488
2. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL 1997 The cost of adverse drug events in hospitalized patients. JAMA 277: 307-311
3. Bégaud B, Evreux JC, Jouglard J, Lagier G 1985 Unexpected or toxic drug reaction assessment (imputation). Therapie 40: 111-118
4. Bordet R, Gautier S, Le Louet HL, Dupuis B, Caron J 2001 Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol 56: 935-941
5. Classen DC, Pestotnik SL, Evans RS, Lioyd JF, Burke JP 1997 Adverse drug events in hospitalized patients: Excess length of stay, extra cost and attributable mortality. JAMA 227: 301-306
6. CIOMS 1998 Basic requirements for use of terms for reporting adverse drug reactions (X): Gastrointestinal System Disorders. Pharmacoepidemiology and Drug Safety 7: 281-287
7. Cutroneo P, Greco S, Cucinotta G, Arcoraci G, Caputi AP 1999 Spontanous reporting of adverse drug reactions in elderly patients in Sicily. Pharmacol Res 40 (Suppl 1): 41-46
8. Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U, Stocker DN, Braunschweig S, Kullack-Ublick GA, Galeazzi RL, Follath F, Gasser T, Meier PJ 2000 Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 49 (Suppl 2): 158-167
9. Göttler M, Schneeweiss S, Hasford J 1997 Adverse drug reaction monitoring - cost and benefit considerations part II: Cost and preventability of adverse drug reaction leading to hospital admission. Pharmacoepidemiology and Drug Safety 6 (Suppl 3): 79-90
10. Helal A 1998 Canadian Adverse Drug Reaction Newsletter; Quality information in spontanous reports. CMAJ 159: 87
11. Kando JC, Yonkers KA, Cole JO 1995 Gender as a risk factor for adverse events to medications. Drugs 50: 1-6
12. Lepori V, Perren A, Marone C 1999 Unerwünschte internmedizinische Arzneimittelwirkungen bei Spitaleintritt. Schweiz Med Wochenschr 129: 915-922
13. Lin SH, Lin MS 1993 A survey on drug-related hospitalisation in a community teaching hospital. Intent J Clin Pharmacol Therap Toxicol 31: 66-69
14. Monastruc JL, Lapeyre-Mestre M, Baheri H, Fooladi A 2002 Gender differences in adverse drug reactions: analysis of spontaneous reports to a regional Pharmacovigilance Centre in France. Fundam Clin Pharmacol 16: 343-346
15. Mühlberger N, Schneeweiss S, Hasford J 1997 Adverse drug reaction monitoring - cost and benefit considerations part I: Frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiology and Drug Safety 6 (Suppl 3): 71-73
16. Rawlins MD 1981 Clinical Pharmacology: Adverse reactions to drugs. Br Med J Clin Res Ed 282: 974-976
17. Schneeweiss S, Göttler M, Hasford J, Swoboda W, Hippius M, Hoffmann A, Riethling AK, Krappiveis J 2001 First results from an intensified monitoring system to estimate drug related hospital admissions. Br J Clin Pharmacol 52: 196-200
18. Schumock GT, Thornton JP, Witte KW 1991 Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions. Am J Hosp Pharm 48: 1974-1976
19. Simiand-Erdociain E, Lapeyre-Mestre M, Bagheri-Charabiani H, Monastruc JL 2001 Drug consumption in a very elderly community-dwelling population. Eur J Clin Pharmacol 57: 691-692
20. Stoukides CA, D'Agostino P, Kaufman MB 1993 Adverse drug reaction surveillance in an emergency room. Am J Hosp Pharm 50: 712-714
21. Thomas EJ, Brennan TA 2000 Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ 320: 741-744
22. World Health Organisation 1972 International drug monitoring. The role of National Centres. Technical Report Series No. 498